Milad Alucozai

Co-Founder

2024 - Current

We work closely with hospitals and organ procurement organizations to enable organ donation after patients pass away from incurable diseases like lung cancer that traditionally prevent donation for clinical transplantation. We then bring those organs back to life on organ perfusion technology to run transformative research studies aimed at accelerating the development of breakthrough biomedical innovations without putting patient’s lives at risk.

Co-Founder & Co-Host Code to Cure Series

2024

First investor and Board Member

2020

First investor and board member. Seqera is building the modern biotech stack by making scientific data analysis accessible at any scale. Seqera is the best solution for running robust, high-throughput computing at scale. From your first pipeline to running 10,000+ concurrent CPUs or workflows with >1,000,000 tasks, Seqera's architecture will grow with you - ensuring that computational bottlenecks never hinder scientific endeavors.

Visiting Scientist & Senior Advisor

2024

To become a leading independent research institute in the discovery and development of innovative solutions to improve human health. https://www.indianabiosciences.org/

Senior Advisor

2024

16 Tech is a 50-acre innovation district in downtown Indianapolis dedicated to world-changing innovation and economic opportunity.

Strategic Expert in Residence

2024

Through Digitalis Commons, I am a Strategic Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where I support the US government and ARPA-H mission of enabling transformative biomedical and health breakthroughs to provide health solutions for all through non-dilutive investments. https://arpa-h.gov/

Member

2024

Established in 2009, C100 is a non-profit association with a mission to showcase exceptional leadership, harness extraordinary international talent, and fuel the pursuit of daring entrepreneurial ambitions in Canada.

Mentor - Recipient of Mentor of the Year Award

2019

Recipient of Mentor of the Year Award. Creative Destruction Lab (CDL) is a nonprofit organization that delivers an objectives-based program for massively scalable, seed-stage, science- and technology-based companies. Its nine-month program allows founders to learn from experienced entrepreneurs, increasing their likelihood of success. The program has expanded to 12 sites across six countries. Participating ventures have created $28 billion (CAD) in equity value.

Board Member

2023

Talus Bio is a venture-backed early-stage biotechnology startup company working on drug development for gene regulators. Talus spun out of two leading institutions in September 2020 (University of Washington and Altius Institute for Biomedical Sciences) and is located in Seattle, WA. We are building a data-enabled drug development platform that will focus primarily on small-molecule drug development in oncology.

Head of Life Sciences & Deep Tech

2018 - 2024

After nearly six incredible years, I have officially left BoxOne Ventures, filled with gratitude and excitement. My journey has been transformative, and I am immensely proud of what we have achieved together. In 2018, I met Josh at Creative Destruction Lab. We connected over our mutual passion for pushing the boundaries of bioengineering and computational advancement. We immediately began finding ways to work together and make investments, often as the first check into startups run by world-class founders. Fast forward nearly six years, we've built a firm recognized as one of the most active early-stage investors, with a portfolio exceeding 100 companies and multiple successful exits. Our brand stands as a testament to our founders and community partners who collaborate with us to make this possible.